Article | August 16, 2016

Concomitant Medications In Clinical Trials: Why The Stakes Are High

Concomitant Medications In Clinical Trials: Why The Stakes Are High

By Craig Morgan NZCS, MBA (Hons), PMP, goBalto, Inc.

Almost every reported concomitant medication has a reason – and many, if not all of these reasons should be reported as adverse events. Concomitant medications (a.k.a., con-meds) are other prescription medications, over-the-counter (OTC) drugs or dietary supplements that a study participant takes in addition to the drug under investigation. Con-meds may be used by study subjects for the same indication as the study or for other indications.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Clinical Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
I'm interested in newsletter subscriptions.
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: